The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected locally advanced non-small cell lung cancer
To access this article, please choose from the options below
PII: S0169-5002(09)00501-7
doi:10.1016/j.lungcan.2009.10.002
© 2009 Elsevier Ireland Ltd. All rights reserved.
